Episodes
Monday Aug 08, 2022
Bell2Bell Podcast featuring Nemaura Medical Inc. CEO Dr. Faz Chowdhury
Monday Aug 08, 2022
Monday Aug 08, 2022
Bell2Bell’s latest podcast features Dr. Faz Chowdhury, Chairman and CEO of Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing and commercializing affordable diagnostic and digital tools for chronic disease management.
Throughout the interview, Chowdhury provided an introduction to Nemaura Medical and discussed its business model.
“Nemaura Medical was founded just over a decade back, and, over that period of time, we’ve been focused on developing a body-worn sensor designed for both consumer and medical applications in the diabetes space,” Chowdhury said. “We use the sensor to look at insight you otherwise could not gauge just by using existing technologies – taking a drop of blood and putting it on a strip, for example… It has taken us a good part of the 10 years to develop the technical aspects of the product, get the clinical studies done and get regulatory approvals in Europe. Now, we are already commercializing product in the UK, and we are looking at launching in other places in Europe and then into the U.S.”
Monday Aug 08, 2022
Monday Aug 08, 2022
Bell2Bell’s latest podcast features Dr. Faz Chowdhury, Chairman and CEO of Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing and commercializing affordable diagnostic and digital tools for chronic disease management.
Throughout the interview, Chowdhury provided an introduction to Nemaura Medical and discussed its business model.
“Nemaura Medical was founded just over a decade back, and, over that period of time, we’ve been focused on developing a body-worn sensor designed for both consumer and medical applications in the diabetes space,” Chowdhury said. “We use the sensor to look at insight you otherwise could not gauge just by using existing technologies – taking a drop of blood and putting it on a strip, for example… It has taken us a good part of the 10 years to develop the technical aspects of the product, get the clinical studies done and get regulatory approvals in Europe. Now, we are already commercializing product in the UK, and we are looking at launching in other places in Europe and then into the U.S.”
Tuesday Aug 02, 2022
Bell2Bell Podcast featuring CEO of Aditxt, Inc. (ADTX), Amro Albanna
Tuesday Aug 02, 2022
Tuesday Aug 02, 2022
Bell2Bell’s latest podcast features Amro Albanna, Co-Founder, Chairman and CEO of Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a biotech innovation company.
Throughout the interview, Albanna provided an introduction to Aditxt and discussed its business model.
“We are a biotech innovation company, and our focus is on immune diseases. The reality is that immune diseases are caused either by someone having too little immune response or too much immune response,” Albanna said. “When you have too little immune response and you’re dealing with COVID-19, we all understand the story, and that applies to other viral diseases. Too much immunity is also not a good thing. When you have too much immune response, you get into the area of autoimmune diseases – multiple sclerosis, type I diabetes, and psoriasis. These all happen when our immune system begins to overreact and attack our own tissues and cells.”
Join IBN’s Stuart Smith and Amro Albanna to learn more about the company’s seasoned management team, as well as its recent milestones and goals for the balance of 2022 and beyond.
Tuesday Aug 02, 2022
Tuesday Aug 02, 2022
Bell2Bell’s latest podcast features Amro Albanna, Co-Founder, Chairman and CEO of Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a biotech innovation company.
Throughout the interview, Albanna provided an introduction to Aditxt and discussed its business model.
“We are a biotech innovation company, and our focus is on immune diseases. The reality is that immune diseases are caused either by someone having too little immune response or too much immune response,” Albanna said. “When you have too little immune response and you’re dealing with COVID-19, we all understand the story, and that applies to other viral diseases. Too much immunity is also not a good thing. When you have too much immune response, you get into the area of autoimmune diseases – multiple sclerosis, type I diabetes, and psoriasis. These all happen when our immune system begins to overreact and attack our own tissues and cells.”
Join IBN’s Stuart Smith and Amro Albanna to learn more about the company’s seasoned management team, as well as its recent milestones and goals for the balance of 2022 and beyond.
Tuesday Jul 26, 2022
Bell2Bell Podcast featuring Hillcrest Energy Technologies Ltd. CEO Don Currie
Tuesday Jul 26, 2022
Tuesday Jul 26, 2022
Bell2Bell’s latest podcast features Don Currie, CEO of Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA), a clean technology company based in Vancouver, British Columbia.
Throughout the interview, Currie provided an introduction to Hillcrest Energy and discussed its business model.
“We’re a clean tech innovation company. Our mission is to create solutions that unlock efficiencies in electrification and maximize the performance of an integrated electric system, now and in the future,” Currie said. “What we’re finding is that, with some of the technology we have in place or are working on, tomorrow is today. We’re quite excited about some of the things that we have.”
Tuesday Jul 26, 2022
Tuesday Jul 26, 2022
Bell2Bell’s latest podcast features Don Currie, CEO of Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA), a clean technology company based in Vancouver, British Columbia.
Throughout the interview, Currie provided an introduction to Hillcrest Energy and discussed its business model.
“We’re a clean tech innovation company. Our mission is to create solutions that unlock efficiencies in electrification and maximize the performance of an integrated electric system, now and in the future,” Currie said. “What we’re finding is that, with some of the technology we have in place or are working on, tomorrow is today. We’re quite excited about some of the things that we have.”
Thursday Jul 21, 2022
Thursday Jul 21, 2022
Bell2Bell’s latest podcast features Edward Sylvan, Co-Founder and CEO of Sycamore Entertainment Group Inc. (OTC: SEGI), a diversified entertainment company.
Throughout the interview, Sylvan provided an introduction to Sycamore Entertainment Group and discussed its business model.
“Sycamore Entertainment Group is a full-service marketing and distribution company that operates in film and television within the entertainment industry,” Sylvan said. “What that means is that we’re the people who take finished films and television shows and get them to the mainstream audience either through making films available in local theaters or having them available on streaming platforms.”
Thursday Jul 21, 2022
Thursday Jul 21, 2022
Bell2Bell’s latest podcast features Edward Sylvan, Co-Founder and CEO of Sycamore Entertainment Group Inc. (OTC: SEGI), a diversified entertainment company.
Throughout the interview, Sylvan provided an introduction to Sycamore Entertainment Group and discussed its business model.
“Sycamore Entertainment Group is a full-service marketing and distribution company that operates in film and television within the entertainment industry,” Sylvan said. “What that means is that we’re the people who take finished films and television shows and get them to the mainstream audience either through making films available in local theaters or having them available on streaming platforms.”
Wednesday Jun 29, 2022
Bell2Bell-Bell2Bell Podcast featuring Duane Alexander, CEO of Prime Harvest Inc.
Wednesday Jun 29, 2022
Wednesday Jun 29, 2022
Bell2Bell’s latest podcast features Duane Alexander, Founder and CEO of Prime Harvest Inc., a technology-focused, full-service cannabis company.
Throughout the interview, Alexander provided an introduction to Prime Harvest before discussing his extensive background in the cannabis space.
“Prime Harvest is a vertically integrated cannabis company. We’re based out of San Diego… and we’re positioned to expand into other markets in the State of California,” Alexander said. “We work in the licensing aspect [of the cannabis industry] and compliance. We also work in distribution, as well as branding and marketing.”
Wednesday Jun 29, 2022
Bell2Bell Podcast featuring Duane Alexander, CEO of Prime Harvest Inc. [Video Edition]
Wednesday Jun 29, 2022
Wednesday Jun 29, 2022
Bell2Bell’s latest podcast features Duane Alexander, Founder and CEO of Prime Harvest Inc., a technology-focused, full-service cannabis company.
Throughout the interview, Alexander provided an introduction to Prime Harvest before discussing his extensive background in the cannabis space.
“Prime Harvest is a vertically integrated cannabis company. We’re based out of San Diego… and we’re positioned to expand into other markets in the State of California,” Alexander said. “We work in the licensing aspect [of the cannabis industry] and compliance. We also work in distribution, as well as branding and marketing.”